Dr. Sophie G. Fletcher, MD

Dr. Fletcher practices at Santa Rosa Surgery and Endoscopy Center in Santa Rosa, California.

Dr. Fletcher's NPI, 1093924714, was assigned on May 21, 2007. Dr. Fletcher graduated from University of Pittsburgh School of Medicine in 2002. Dr. Fletcher's Texas license number on file is M6132.

Dr. Fletcher's primary practice is Santa Rosa Surgery and Endoscopy Center, at 34 Mark West Springs Road, Suite 100, Santa Rosa, CA 95403. The practice phone is (707) 541-3500.

Dr. Fletcher's primary practice is Santa Rosa Surgery and Endoscopy Center in Santa Rosa, California. Dr. Fletcher is also affiliated with Sutter Santa Rosa Regional Hospital. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Fletcher to 4 more hospitals, 5 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fletcher practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Fletcher's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Fletcher is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dmand AI has Dr. Fletcher's licenses on file in 3 states: Texas, California and Mississippi.

Dmand AI lists bladder disease, enlarged prostate, kidney cysts, kidney removal surgery, kidney stone disease, pelvic prolapse, prostate cancer and urinary endoscopy among the conditions Dr. Fletcher treats.

CMS data shows 25,809 Medicare services from Dr. Fletcher across 25 procedure codes in 2024, for 568 Medicare patients. Medicare paid $376,108 for them.

CMS counts 568 Medicare patients who saw Dr. Fletcher in 2024. The largest group is 75 to 84, with 228 patients. 73% of them have high cholesterol, and 66% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fletcher's median patient age at 72, with 79% women.

In 2024, Dr. Fletcher wrote 1,337 Medicare Part D claims for 416 patients. 47% of them were for generic drugs. CMS names the drug for 1,254 of them, across 16 drugs with 11 or more claims each, at $520,557 in total drug cost. In 2023, CMS named 1,133 claims across 15 drugs.

Dr. Fletcher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fletcher as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Fletcher, published from 2008 to 2016. 2008 was the busiest year, with 2. The most frequent topics are Urodynamics, Brain and Multiple Sclerosis. Dr. Fletcher has published most often in J Urol. Dr. Fletcher's most frequent co-authors are Gary Evan Lemack, MD, Rose Khavari, MD and Timothy Bolton Boone, MD, PhD.

Dmand AI links Dr. Fletcher to 1 clinical trial. Conditions studied include Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis.

CMS Open Payments shows 72 general payments to Dr. Fletcher from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Medtronic, Inc. paid the most, $395.

Dr. Fletcher graduated from University of Pittsburgh School of Medicine in 2002.

Dr. Fletcher is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.